SC 13G/A:超過5%持股股東披露文件(修正)-Anson Funds Management LP(4.9%),Anson Management GP LLC(4.9%)等
4:持股變動聲明-董事 Cashmere Karen A.
4:持股變動聲明-高管 Glover Stephen C.
4:持股變動聲明-高管 Wolfe Peter
4:持股變動聲明-董事 Park Min-Chul
4:持股變動聲明-董事 Freitag Gregory Gene
4:持股變動聲明-董事 SAPIRSTEIN JAMES
4:持股變動聲明-董事 Finizio Robert G
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | SC 13G/A:超過5%持股股東披露文件(修正)-Ionic Ventures, LLC(4.0%),Ionic Management, LLC(4.0%)等
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | SC 13G:超過5%持股股東披露文件-Anson Funds Management LP(9.8%),Anson Management GP LLC(9.8%)等
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | SC 13G/A:超過5%持股股東披露文件(修正)-L1 Capital Global Opportunities Master Fund Ltd.(0%)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | SC 13G/A:超過5%持股股東披露文件(修正)-INCON Co., Ltd.(3.44%)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | 4:持股變動聲明-股東 INCON Co., Ltd.
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | SC 13G:超過5%持股股東披露文件-L1 Capital Global Opportunities Master Fund Ltd. (1)(8.6%)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | SC 13D/A:超過5%持股股東披露文件(修正)-Stephen Glover(6.76%)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | SC 13D/A:超過5%持股股東披露文件(修正)-Daniel J. O’Connor(7.70%),Larkspur Health LLC(7.61%)
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | SC 13G:超過5%持股股東披露文件-Ionic Ventures, LLC(9.99%),Brendan O’Neil(9.99%)等
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | SC 13G/A:超過5%持股股東披露文件(修正)-Oaktree Holdings, LLC(0.0%),OCM Value SPAC Holdings, L.P.(0.0%)等
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | SC 13G:超過5%持股股東披露文件-A.G.P. / Alliance Global Partners, LLC(8.9%),Alliance Global Holdings, Inc.(8.9%)等
ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) | SC 13G/A:超過5%持股股東披露文件(修正)-Lighthouse Investment Partners, LLC(0.0%),MAP 136 Segregated Portfolio, a segregated portfolio of LMA SPC(0.0%)
暫無數據
暫無數據